Market Overview:
The global postural orthostatic tachycardia syndrome (POTS) treatment market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The primary forms segment is expected to dominate the market in terms of revenue share during the forecast period. The hospitals segment is estimated to account for a major share of the global POTS treatment market in 2018 and is projected to maintain its dominance throughout the forecast period. North America dominates the global POTS treatment market, followed by Europe and Asia Pacific.
 Treatment Industry Outlook.svg)
Product Definition:
Postural Orthostatic Tachycardia Syndrome (POTS) is a disorder of the autonomic nervous system. The autonomic nervous system controls all the "automatic" functions of the body, such as heart rate, digestion, and breathing. In people with POTS, the autonomic nervous system does not work properly. This can lead to problems such as an increase in heart rate (tachycardia), lightheadedness or dizziness when standing up (orthostatic intolerance), and other symptoms.
Primary Forms:
Primary forms of Postural Orthostatic Tachycardia Syndrome (POTS) Treatment include the use of anti-epileptogenic drugs, beta-blockers and vasodilators. The most commonly used drug class for POTS treatment is the Vasodilator group which includes Nitroglycerin, Isosorbide dinitrate and Sildenafil citrate.
Secondary Forms:
Secondary forms are used in the treatment of POTS. It is also known as postural orthostatic tachycardia syndrome (POTS) or orthostatic tachycardia. This condition is characterized by an increase in heart rate on standing and may lead to fainting.
Application Insights:
Based on application, the global postural orthostatic tachycardia syndrome (POTS) treatment market is segmented into hospitals, clinics and ambulatory surgical centers and research institutes. Hospitals held the largest share in 2017 owing to factors such as availability of advanced healthcare facilities along with highly skilled medical staff. POTS treatment in hospital settings includes initial evaluation followed by management through a combination of medications and therapies.
The clinics & ambulatory surgical centers segment is expected to grow at a faster rate during the forecast period due to increasing awareness among patients regarding diagnosis and treatment options for POTS. Moreover, rising cases of obesity are resulting in more number of patients suffering from Postural Tachycardia Syndrome (PTS). According to data published by WHO, globally around 35% women & 25% men are obese which amounts to over 1 billion women & 2 billion men across the world who suffer from this condition every year making it one of the most common chronic diseases affecting humans globally.
Regional Analysis:
North America dominated the global postural orthostatic tachycardia syndrome (POTS) treatment market in 2017. This can be attributed to the presence of a large number of POTS patients, increased healthcare expenditure, and availability of highly advanced healthcare infrastructure. Moreover, rising awareness about various treatments available for POTS is also expected to drive regional growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increasing prevalence rates and awareness campaigns by various organizations such as Postural Orthostatic Tachycardia Syndrome Foundation (POTSF), International Society for Postural Orthopedics & Traumatology (ISPO), American Physical Therapy Association (APTA) among others.
Growth Factors:
- Growing awareness about POTS and its symptoms: There is a growing awareness about POTS among people, especially the youth. This is because of the increasing number of cases being reported in the media. As a result, there is an increase in demand for POTS treatment products and services.
- Development of new drugs and therapies for treating POTS: The development of new drugs and therapies for treating POTS has led to an increase in demand for these products. This has helped to boost the growth of the Postural Orthostatic Tachycardia Syndrome (POTS) Treatment market.
- Rise in incidence rate of POTS: The incidence rate of POTS is on the rise due to various factors such as changes in lifestyle, increased stress levels, etc. This has resulted in an increase in demand for Postural Orthostatic Tachycardia Syndrome (Pots) Treatment products and services worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Research Report
By Type
Primary Forms, Secondary Forms
By Application
Hospitals, Clinics, Ambulatory Surgical Centers, Research Institutes
By Companies
Pfizer, Novartis, AstraZeneca, Merck, Sanofi, Daiichi Sankyo, Bayer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
194
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Report Segments:
The global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment market is segmented on the basis of:
Types
Primary Forms, Secondary Forms
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers, Research Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Novartis
- AstraZeneca
- Merck
- Sanofi
- Daiichi Sankyo
- Bayer
 Treatment Market Overview.svg)
Highlights of The Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Primary Forms
- Secondary Forms
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Treatment Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best treatment for POTS will vary depending on the individual's symptoms and medical history. However, some common treatments for POTS include: 1) Treating underlying causes of the syndrome, such as dehydration or a thyroid disorder. 2) Taking medications to lower blood pressure or improve heart function. 3) Using exercise therapy to help increase blood flow and improve overall fitness levels.
Some of the key players operating in the postural orthostatic tachycardia syndrome (pots) treatment market are Pfizer, Novartis, AstraZeneca, Merck, Sanofi, Daiichi Sankyo, Bayer.
The postural orthostatic tachycardia syndrome (pots) treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size & Forecast, 2020-2028
4.5.1 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size and Y-o-Y Growth
4.5.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Primary Forms
5.2.2 Secondary Forms
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Ambulatory Surgical Centers
6.2.4 Research Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Primary Forms
9.6.2 Secondary Forms
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Ambulatory Surgical Centers
9.10.4 Research Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Primary Forms
10.6.2 Secondary Forms
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Ambulatory Surgical Centers
10.10.4 Research Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Primary Forms
11.6.2 Secondary Forms
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Ambulatory Surgical Centers
11.10.4 Research Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Primary Forms
12.6.2 Secondary Forms
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Ambulatory Surgical Centers
12.10.4 Research Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Primary Forms
13.6.2 Secondary Forms
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Ambulatory Surgical Centers
13.10.4 Research Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market: Competitive Dashboard
14.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Novartis
14.3.3 AstraZeneca
14.3.4 Merck
14.3.5 Sanofi
14.3.6 Daiichi Sankyo
14.3.7 Bayer
